A cure for Type 1 diabetes has come one step closer as Vertex reports 90-day results for its synthetic insulin cell therapy.
Dermatologists point to several uptake openings for JAK inhibitors in moderate-to-severe eczema despite highly publicized side effect concerns.
The clinical-stage company has announced that its Covid-19 vaccine candidate, SCB-2019, is 67% effective against the virus.
Sanofi’s pemphigus asset, Artios solid tumor trial among recent events reviewed by GlobalData’s Investigative News team.
GlobalData’s Investigative News team reviews recent events that impacted a drug’s path to regulatory approval.